Home Forums General Discussion Novel treatment with Dapsone for Lyme "persisters"

This topic contains 0 replies, has 1 voice, and was last updated by  Maz 1 year, 7 months ago.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #455644
    Maz
    Keymaster

    A recent study has demonstrated promise for treating patients persistent chronic Lyme with Dapsone in combination with other antibiotics:

    http://www.omicsonline.org/open-access/the-use-of-dapsone-as-a-novel-persister-drug-in-the-treatment-of-chroniclyme-diseasepost-treatment-lyme-disease-syndrome-2155-9554-1000345.pdf

    Dapsone is a sulpha derivative and so would likely not be suitable for anyone with sulpha allergy. However it is commonly used for skin conditions, including leprosy, toxoplasmosis, acne and dermatitis herpetformis, as well as pneumocystic pneumonia.

    Severe, swift onset RA as a result of Lyme disease
    Current Meds: Biaxin (500mg BID), Tetracycline (500mg BID), Tirosint (88mcg), Liothyronine (10 mcg), Compounded Liposomal Artemisinin, LDN (3mg), Topical Progesterone,
    Current Supps: Curcumin, Bovine Colostrum, ALA. NAC, Milk Thistle, Super Liquid Folate/B12/B-Complex, Probiotics, Vit D3
    Supportive Measures: IV Myer's Cocktails, IV Glutathione, FIR Sauna, Gluten-free diet, Gym.

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.